<a href="https://support.doctorpodcasting.com/media/k2/items/cache/eb693f24d9f85b6fafe38111a7618def_Generic.jpg"><img align="right" border="0" src="https://support.doctorpodcasting.com/media/k2/items/cache/eb693f24d9f85b6fafe38111a7618def_S.jpg" alt="pluvicto-for-metastatic-castrate-resistant-prostate-cancer" /></a>Robert Zlotecki M.D., PhD describes the factors that make a patient a candidate for Pluvicto treatment for prostate cancer. He explains the process of treatment through a series of Pluvicto infusions for prostate cancer and he outlines the current shift in thinking regarding systemic radiopharmaceutical therapy for prostate cancer.

Robert Zlotecki M.D., PhD describes the factors that make a patient a candidate for Pluvicto treatment for prostate cancer. He explains the process of treatment through a series of Pluvicto infusions for prostate cancer and he outlines the current shift in thinking regarding systemic radiopharmaceutical therapy for prostate cancer.

<a href="https://support.doctorpodcasting.com/media/k2/items/cache/eb693f24d9f85b6fafe38111a7618def_Generic.jpg" rel="noopener noreferrer"></a>Robert Zlotecki M.D., PhD describes the factors that make a patient a candidate for Pluvicto treatment for prostate cancer. He explains the process of treatment through a series of Pluvicto infusions for prostate cancer and he outlines the current shift in thinking regarding systemic radiopharmaceutical therapy for prostate cancer.

Pluvicto for Metastatic Castrate Resistant Prostate Cancer

Earn CME credits while learning about trending clinical topics and research advances from UF Health Shands Hospital experts.

Share Pluvicto for Metastatic Castrate Resistant Prostate Cancer

Sign up to save your podcasts

Pluvicto for Metastatic Castrate Resistant Prostate Cancer

Pluvicto for Metastatic Castrate Resistant Prostate Cancer

More shows like UF Health MedEd Cast

TED Radio Hour